Click here to load reader
Click here to load reader
ASSIGNMENT COVER SHEET(to be completed by the student)
Student ID number: A 12428
Student name: Magalie Terry
Course name: DISTANT LEARNING MBA
Subject name: STRATEGIC MANAGEMENT
Subject facilitator:
No. of pages: 10
Word count: 1551
DECLARATION
I, the above named student, confirm that by submitting, or causing the attached assignment to be submitted, to AIB, I have not plagiarised any other person’s work in this assignment and except where appropriately acknowledged, this assignment is my own work, has been expressed in my own words, and has not previously been submitted for assessment.
CHECKLIST
Please complete the following checklist before submitting your assignment to AIB
Have you completed all sections of this Assignment Cover Sheet?
Is your assignment in ‘word’ format (i.e. Office Word 2003.doc format)? AIB will not accept assignments in any other format?
Is your assignment saved as “your full name” and “the name of the subject”? For example, the assignment document may be saved as “Jane Citizen - Leadership”.
Are you emailing your assignment and this completed Assignment Cover Sheet to [email protected]? AIB will not accept hardcopy assignments?
Does the subject line in your email state (1) your full name (2) your student identification number (3) which subject your assignment relates to?
Will you retain confirmation of the time that you are emailing your assignment to AIB? This Assignment Cover Sheet and your assignment must be received by AIB before the deadline?
2
ASSESSMENT SHEET(to be completed by the examiner)
Student name: Magalie Terry
Course name: MBA
Subject name: Strategic Management
Assessor/marker:
COMMENTSPrinciples used (for example, number and understanding of concepts referred to, their influence on the structure of this paper, number and correct citations of references, use of appropriate jargon)
/4
Application of those principles, that is, the analysis and evaluation of the example problem based on the principles, including the final recommendations and their justification
/8
How well the example problem was described, including the extent and depth of information (including the data) about it that was accessed
/4
Structure and presentation
/2
Style, grammar and language
/2
Total Less penalties
GRAND TOTAL /20General comments
FOR MODERATOR’S USE ONLY
I agree with the assessor’s assessment I disagree with the assessor’s assessment and the new mark is as follows for the following reasons:
/20
Moderator:
Title: Strategic planning.
Assignment Topic:
Develop a mission statement of values and explain their appropriateness
Undertake an internal analysis of the organisation and an analysis of its external
environment using several appropriate tools like an industry five forces analysis
Craft strategies and explain their appropriateness.
Executive Summary : The Strategic Planning of a laser distributor. The difficulties it faces
vis a vis subsidiaries and the elaborate market in which it competes at different levels in a
very diversified market. Yet it is possible to use the appropriate tools to craft a strategy and
show how different market have different issues
Introduction:
The existing company does not have a mission statement per say or a vision statement but it
does have some core values and goes by an Ethos that best describes the company. The
mission statement shows the stakeholders and the shareholders what XLASER (Fictitious
Name) does best and why they want to do it. It is focused brief and easy to remember. The
vision statement is to show how passionate this distributor is and both the statement
encapsulate the core values of the company.
MISSION STATEMENT- VISION STATEMENT- CORE VALUE STATEMENT:
Mission Statement:
Our aim is to share our clinical, technical and marketing expertise with all our partners in the
aesthetic industry by providing you with the most innovative Lasers/IPL platforms for the
optimal results in the most the most ethical way. We believe that in growing our market
share by 10% every year we will encourage our suppliers to stay at the forefront in delivering
the best product to your clinic and your patients.
Vision Statement:
We are passionate in helping the aesthetic clinics create the “New You” for their clients and
in doing so we empower our people to deliver our ethos “Products you know from people you
trust” for a many years to come.
Value Statement:
Innovation: Encourage creativity among our people who in turn will share it with our
customers.
Excellence: We are committed at every level of our value chain in delivering the best
Technical, Clinical Support. Training & after sales service are our expertise. We consider the
doctor and patients first.
Integrity: Follow & adhere to our ISO standards – TGA recommendations and act in a fair
and ethical fashion.
Respect: We recognise that we are all different and important to each other both within the
company and with our customers. Let us join forces to unite our strengths.
SWOT ANALYSIS – AESTHETIC MARKET
STRENGHTS
Unique Quality products from renowned suppliers
Small enough to adapt to changes
Strong clinical expertise
Well-resourced clinical data
Directors well respected (12 years in the industry)
Evidence Based devices in product portfolio
Medium size overheads
Good Technical support (three Engineers)
Differentiation in Technology-Clinical support &
technical Support as well as providing ROI to every
buyer and help with marketing material.
Marketing material for support already available
Incredible profit margins do not need to sell a great
quantity.
WEAKNESSES
Immature sales team with few skill sets
Difficult to focus due to wide product range
Weak market presence due to no great products for a
few years.
No clear strategic direction
Lack of follow-up post sales meetings
Poor market intelligence feedback
Sales Presence in New Zealand rare?
No service person in Vic or Qld
Directors lack of presence in market
Too many products / lack of focus
Retainer too high which does not encourage striving
for performance
No real culture in the organisation
High Transfer price from suppliers and no real
negotiating powers
No KOL programme
OPPORTUNITIES
Wider portfolio than competitors
Strength of the Australian dollar / better pricing
Impulse purchase (one decision maker)
Quick buying cycles/fast moving and competitive
industry
Substitute will complement not so much compete
High demand for these procedures
High ROI.
THREATS
Lack of government incentives/TGA ruling
Hard to maintain market share / marketing efforts
Lack of market intelligence i.e. installed base of
competitors
New Substitute
Natural Disasters such as Earthquake in NZ
Potential New Entrants with second-hand market and
cheap imports are on the increase
EXTERNAL ENVIRONMENT: XLASER has been affected by all the above forces and
stands to be threatened in the future.
Demographics: 35 -65 years captive audience for laser treatment as the Australian
population is ageing the end users may decrease.
Social: Invasive/Non-Invasive enhancement may not always be favoured. Doctors
concerned about beautician entering the market with lower cost offering.
Political, Legal and Regulatory Affairs: There is a strong push to bring in legislation to
regulate the industry. Also the TGA has relaxed the requirements for listing of aesthetic
lasers encouraging lower standards to cut prices. Banks are more reluctant to loan such high
risk investments...
Natural Environment: Natural disasters such as Christchurch Earthquake –market not yet
recovered - Insurances for laser procedures are on the rise.
Technological Factors: Fast pace industry for technology early adopters give a very short
window to operate.
Global Forces: While XLASER only exports to New Zealand still affected by exchange rate.
General Economic Conditions: Fortunately GFC or any financial downturn has a positive
response from the market they feel down and want to look better.
COMPETITIVE ENVIRONMENT :
Using Porter’s Five Forces Analysis:
The industry has Four Strategic Groups:
1. Skincare/Dermabraision: Costly to end- user but good ROI for the clinic.
2. Injectables: Again costly to the end-user but good ROI with little outlay to the clinic.
3. Non-Invasive Laser/IPLInterventions: Any age multiple use - longer term results costly to
the end user short term but not long term and large initial capital investment for the clinic
4. Invasive Laser/IPL Interventions: Any age multiple use - longer term results costly to the
end user short term but not long term and large initial capital investment for the clinic.
XLASER occupies the two last categories. While these technologies are in the higher price
bracket they are competitively valuable as they are unique, there are no such innovative
products among our rivals and they are difficult to copy because they have unique features
and hold strong patents. No substitute can replace the treatments they provide.
XLASER also offers a unique 3D Quantitative imaging system as part of the package to
complement our core value Doctors and Patients first.
However XLASERS had not performed well in the last three years prior to one of the bigger
supplier coming on board early last year. The primary stakeholders who are the doctors and
the Buyers don’t have a lot of experience with the company as they had old technology prior
and in some ways have had a poor image in the industry.
MARKET SHARE
CO
ST
&
QU
AL
ITY
The secondary stakeholders and indirectly also the Buyers are the end users; they have little
to no say in what their doctor use. One company such as FRX is a one product company and
has resorted to extensive advertising to the end users which has made the product become a
household name and has therefore increase their market share tremendously.
Suppliers: XLASER does not have a great bargaining power with its biggest supplier as it is
a new partnership and has not yet been successful enough. Prices are set.
New Entrants are a threat and will mostly be (1) cheap copies from Asia with little to no
clinical support (2) The second hand /refurbished market supplied by E-med, where cost has
eroded the ethics of good training and reliability.
At this stage XLASER sits in the very left corner of the Strategic Group Map and the Goal is
to move it towards the middle top quadrant. The reason for its lack of performance is mostly
due to a non-experience sales force.
Strategic Group Map
Adapted from Crafting & Executing Strategy Thompson/Peteraf/Gamble/Strickland
DC
PAL
CAND
HL
CUT
XLASERRR
FRXL
QMED
INJECTABLE FILLERS
BOTOX INJECTABLES
SKINCARE/DERMABRAISIO
NS
ROUND SHAPE = Subsidiaries OVAL SHAPES = Distributors SQUARE SHAPES = Substitutes
CRAFTING THE STRATEGIES:
We need exposure and a KOL programme short term so I would propose:
Blue Ocean Strategy with an Alliance
Differentiation:
We have many unique products so differentiation is our biggest advantage, however we really
need to have the exposure to rebuild our image and showcase what we can offer, hence the
following strategy to help this happen
Alliance: With the Fillers/Botox group. Non contractual people to people at a territory level,
synergistic effect to benefit both by using the imaging system in a quantitative way:
(1) The injectable company benefits as a sales tool to sell more when they demo.
(2) The doctor uses it to sell more procedures.
(3) XLASER increases its exposure by using the existing network that the injectable
representative has. Increase presence
This would also be repeated at conferences with an added non competitor contender “An
interior decorating company that enjoys a solid presence in this industry. What will this
do?
(1) Increase Air Time spent for the inexperienced reps.
(2) Unique value proposition with a vertical Integration for the doctors. One stop shop
(3) Build up our image with follow-up visits accompanied by upper management
(4) This would reduce the avenues for the rivals less air time.
(5) Pooling resources means less cost and attending more conferences.
Will the competitors retaliate? Sure but will lag by a year due to booking system at
conferences and they may need other ideas for Alliances.
To measure this implementation the sales representative will need to show follow-up call
rates and enter the leads on the ERP of the company. This I am sure will give us our 10%
increase by asking each representative to sell 1 system after each on the conferences. To be
or not to be a first mover?
References
(1) Charting your company’s future Harvard Business Review 80 No.6 June 2002
(2) Michael E Porter “How competitive Forces shape Strategy” Harvard Business Review
57, no2 (March April 1979
(3) Barney J.B.(1991) Journal of Management 17 (1) 99-120
(4) Chi. T. (1994) Trading in Strategic Resources Strategic Management Journal 15, 271-
290
(5) Coopers and Lybrand (1997) “Strategic Alliances” Coopers and Lybrand Barometer
Spring.
(6) http//:www.allianceanalyst.com (11th November)